{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T23:48:41Z","timestamp":1791676121881,"version":"4.3.4"},"reference-count":209,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T00:00:00Z","timestamp":1791590400000},"content-version":"vor","delay-in-days":282,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s12035-026-06227-7","type":"journal-article","created":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T10:16:04Z","timestamp":1791627364000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The Gut Microbiota\u2013Epilepsy Axis: Bibliometric Trends, Mechanistic Insights, and Microbiota-Targeted Next-Generation Therapeutic Opportunities"],"prefix":"10.1007","volume":"63","author":[{"given":"Ayyaz","family":"Khan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zakir","family":"Ullah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Siraj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Younas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahid","family":"Wahab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdul","family":"Waris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seong-Tshool","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,10]]},"reference":[{"key":"6227_CR1","doi-asserted-by":"publisher","first-page":"e203","DOI":"10.1016\/S2468-2667(24)00302-5","volume":"10","author":"VL Feigin","year":"2025","unstructured":"Feigin VL, Vos T, Nair BS, Hay SI, Abate YH, Abd Al Magied AH, Abd ElHafeez S, Abdelkader A et al (2025) Global, regional, and national burden of epilepsy, 1990\u20132021: a systematic analysis for the global burden of disease study 2021. Lancet Public Health 10:e203\u2013e227. https:\/\/doi.org\/10.1016\/S2468-2667(24)00302-5","journal-title":"Lancet Public Health"},{"key":"6227_CR2","unstructured":"World Health Organization (2024) Epilepsy. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/epilepsy. Accessed 2 September 2026"},{"key":"6227_CR3","doi-asserted-by":"publisher","DOI":"10.1002\/ardp.202400229","volume":"357","author":"A Waris","year":"2024","unstructured":"Waris A, Asim M, Ullah A, Alhumaydhi FA (2024) Various pharmacological agents in the pipeline against intractable epilepsy. Arch Pharm 357:e2400229. https:\/\/doi.org\/10.1002\/ardp.202400229","journal-title":"Arch Pharm"},{"key":"6227_CR4","volume-title":"Intersectoral global action plan on epilepsy and other neurological disorders 2022\u20132031","author":"World Health Organization","year":"2023","unstructured":"World Health Organization (2023) Intersectoral global action plan on epilepsy and other neurological disorders 2022\u20132031. World Health Organization, Geneva. https:\/\/iris.who.int\/handle\/10665\/371495"},{"key":"6227_CR5","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1403232","volume":"15","author":"A Waris","year":"2024","unstructured":"Waris A, Ullah A, Asim M, Ullah R, Rajdoula MR, Bello ST, Alhumaydhi FA (2024) Phytotherapeutic options for the treatment of epilepsy: pharmacology, targets, and mechanism of action. Front Pharmacol 15:1403232. https:\/\/doi.org\/10.3389\/fphar.2024.1403232","journal-title":"Front Pharmacol"},{"issue":"5S","key":"6227_CR6","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/S0929-693X(22)00285-8","volume":"29","author":"M Kuchenbuch","year":"2022","unstructured":"Kuchenbuch M, Chiron C, Milh M (2022) Overview of therapeutic options for epilepsy. Arch Pediatr 29(5S):14-5S19. https:\/\/doi.org\/10.1016\/S0929-693X(22)00285-8","journal-title":"Arch Pediatr"},{"key":"6227_CR7","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1124\/pr.120.019539","volume":"72","author":"W L\u00f6scher","year":"2020","unstructured":"L\u00f6scher W, Potschka H, Sisodiya SM, Vezzani A (2020) Drug resistance in epilepsy: clinical impact, potential mechanisms, and new innovative treatment options. Pharmacol Rev 72:606\u2013638. https:\/\/doi.org\/10.1124\/pr.120.019539","journal-title":"Pharmacol Rev"},{"key":"6227_CR8","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/s41378-026-01166-8","volume":"12","author":"S Montalvo Vargo","year":"2026","unstructured":"Montalvo Vargo S, Hong N, Belloir T, Stanis N, Zhou J, Khateeb K, Hatanaka G, Ahmed Z et al (2026) Smart Dura: a functional artificial dura for multi-modal neural recording and modulation. Microsyst Nanoeng 12:67. https:\/\/doi.org\/10.1038\/s41378-026-01166-8","journal-title":"Microsyst Nanoeng"},{"key":"6227_CR9","doi-asserted-by":"publisher","first-page":"120766","DOI":"10.1016\/j.jns.2023.120766","volume":"452","author":"B Mesraoua","year":"2023","unstructured":"Mesraoua B, Brigo F, Lattanzi S, Abou-Khalil B, Al Hail H, Asadi-Pooya AA (2023) Drug-resistant epilepsy: definition, pathophysiology, and management. J Neurol Sci 452:120766. https:\/\/doi.org\/10.1016\/j.jns.2023.120766","journal-title":"J Neurol Sci"},{"key":"6227_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.742449","volume":"12","author":"M Ding","year":"2021","unstructured":"Ding M, Lang Y, Shu H, Shao J, Cui L (2021) Microbiota\u2013gut\u2013brain axis and epilepsy: a review on mechanisms and potential therapeutics. Front Immunol 12:742449. https:\/\/doi.org\/10.3389\/fimmu.2021.742449","journal-title":"Front Immunol"},{"key":"6227_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2022.104061","volume":"80","author":"M Dahlin","year":"2022","unstructured":"Dahlin M, Singleton SS, David JA, Basuchoudhary A, Wickstr\u00f6m R, Mazumder R, Prast-Nielsen S (2022) Higher levels of Bifidobacteria and tumor necrosis factor in children with drug-resistant epilepsy are associated with anti-seizure response to the ketogenic diet. EBioMedicine 80:104061. https:\/\/doi.org\/10.1016\/j.ebiom.2022.104061","journal-title":"EBioMedicine"},{"key":"6227_CR12","doi-asserted-by":"publisher","first-page":"5576","DOI":"10.3390\/ijms22115576","volume":"22","author":"J Amlerova","year":"2021","unstructured":"Amlerova J, \u0160roubek J, Angelucci F, Hort J (2021) Evidences for a role of gut microbiota in pathogenesis and management of epilepsy. Int J Mol Sci 22:5576. https:\/\/doi.org\/10.3390\/ijms22115576","journal-title":"Int J Mol Sci"},{"key":"6227_CR13","doi-asserted-by":"publisher","first-page":"517797","DOI":"10.3389\/fmicb.2020.517797","volume":"11","author":"X Gong","year":"2020","unstructured":"Gong X, Liu X, Chen C, Lin J, Li A, Guo K, An D, Zhou D et al (2020) Alteration of gut microbiota in patients with epilepsy and the potential index as a biomarker. Front Microbiol 11:517797. https:\/\/doi.org\/10.3389\/fmicb.2020.517797","journal-title":"Front Microbiol"},{"key":"6227_CR14","doi-asserted-by":"publisher","first-page":"3488","DOI":"10.1021\/acschemneuro.0c00431","volume":"11","author":"A Arulsamy","year":"2020","unstructured":"Arulsamy A, Tan QY, Balasubramaniam V, O\u2019Brien TJ, Shaikh MF (2020) Gut microbiota and epilepsy: a systematic review on their relationship and possible therapeutics. ACS Chem Neurosci 11:3488\u20133498. https:\/\/doi.org\/10.1021\/acschemneuro.0c00431","journal-title":"ACS Chem Neurosci"},{"key":"6227_CR15","doi-asserted-by":"publisher","first-page":"55121","DOI":"10.12775\/QS.2024.26.55121","volume":"26","author":"N Doma\u0144ska","year":"2024","unstructured":"Doma\u0144ska N, Bojarska M, Bogucka J, Brzyska A, Kosowska M, Piecewicz-Szcz\u0119sna H (2024) Unveiling the potential of gut microbiota: promising approaches to treat drug-resistant epilepsy. Quality in Sport 26:55121. https:\/\/doi.org\/10.12775\/QS.2024.26.55121","journal-title":"Quality in Sport"},{"key":"6227_CR16","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21082668","volume":"21","author":"M Matija\u0161i\u0107","year":"2020","unstructured":"Matija\u0161i\u0107 M, Me\u0161trovi\u0107 T, \u010cip\u010di\u0107 Paljetak H, Peri\u0107 M, Bare\u0161i\u0107 A, Verbanac D (2020) Gut microbiota beyond bacteria\u2014mycobiome, virome, archaeome, and eukaryotic parasites in IBD. Int J Mol Sci 21:2668. https:\/\/doi.org\/10.3390\/ijms21082668","journal-title":"Int J Mol Sci"},{"key":"6227_CR17","doi-asserted-by":"publisher","DOI":"10.3390\/app14209383","volume":"14","author":"L Pires","year":"2024","unstructured":"Pires L, Gonzalez-Param\u00e1s AM, Heleno SA, Calhelha RC (2024) Gut microbiota as an endocrine organ: unveiling its role in human physiology and health. Appl Sci 14:9383. https:\/\/doi.org\/10.3390\/app14209383","journal-title":"Appl Sci"},{"key":"6227_CR18","doi-asserted-by":"publisher","first-page":"13397","DOI":"10.1007\/s00210-025-04155-2","volume":"398","author":"A-HS Wadan","year":"2025","unstructured":"Wadan A-HS, El-Aziz MKA, Ellakwa DE-S (2025) The microbiota-gut-brain-axis theory: role of gut microbiota modulators (GMMs) in gastrointestinal, neurological, and mental health disorders. Naunyn Schmiedebergs Arch Pharmacol 398:13397\u201313426. https:\/\/doi.org\/10.1007\/s00210-025-04155-2","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"6227_CR19","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.tifs.2023.06.013","volume":"138","author":"T Ma","year":"2023","unstructured":"Ma T, Shen X, Shi X, Sakandar HA, Quan K, Li Y, Jin H, Kwok L-Y et al (2023) Targeting gut microbiota and metabolism as the major probiotic mechanism-An evidence-based review. Trends Food Sci Technol 138:178\u2013198. https:\/\/doi.org\/10.1016\/j.tifs.2023.06.013","journal-title":"Trends Food Sci Technol"},{"key":"6227_CR20","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00338-20","volume":"35","author":"SG Sorboni","year":"2022","unstructured":"Sorboni SG, Moghaddam HS, Jafarzadeh-Esfehani R, Soleimanpour S (2022) A comprehensive review on the role of the gut microbiome in human neurological disorders. Clin Microbiol Rev 35:e00338-20. https:\/\/doi.org\/10.1128\/CMR.00338-20","journal-title":"Clin Microbiol Rev"},{"key":"6227_CR21","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.cgh.2018.08.067","volume":"17","author":"TS Dong","year":"2019","unstructured":"Dong TS, Gupta A (2019) Influence of early life, diet, and the environment on the microbiome. Clin Gastroenterol Hepatol 17:231\u2013242. https:\/\/doi.org\/10.1016\/j.cgh.2018.08.067","journal-title":"Clin Gastroenterol Hepatol"},{"key":"6227_CR22","doi-asserted-by":"publisher","DOI":"10.1002\/mnfr.201500902","volume":"61","author":"SJ Bultman","year":"2017","unstructured":"Bultman SJ (2017) Interplay between diet, gut microbiota, epigenetic events, and colorectal cancer. Mol Nutr Food Res 61:1500902. https:\/\/doi.org\/10.1002\/mnfr.201500902","journal-title":"Mol Nutr Food Res"},{"key":"6227_CR23","doi-asserted-by":"publisher","first-page":"10023","DOI":"10.1007\/s12035-023-03757-2","volume":"61","author":"S Chen","year":"2024","unstructured":"Chen S, Jiao Y, Han C, Li Y, Zou W, Liu J (2024) Drug-resistant epilepsy and gut-brain axis: an overview of a new strategy for treatment. Mol Neurobiol 61:10023\u201310040. https:\/\/doi.org\/10.1007\/s12035-023-03757-2","journal-title":"Mol Neurobiol"},{"key":"6227_CR24","doi-asserted-by":"publisher","first-page":"6164","DOI":"10.3748\/wjg.v23.i33.6164","volume":"23","author":"G Xie","year":"2017","unstructured":"Xie G, Zhou Q, Qiu C-Z, Dai W-K, Wang H-P, Li Y-H, Liao J-X, Lu X-G et al (2017) Ketogenic diet poses a significant effect on imbalanced gut microbiota in infants with refractory epilepsy. World J Gastroenterol 23:6164\u20136171. https:\/\/doi.org\/10.3748\/wjg.v23.i33.6164","journal-title":"World J Gastroenterol"},{"key":"6227_CR25","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.seizure.2021.03.009","volume":"90","author":"DM Mej\u00eda-Granados","year":"2021","unstructured":"Mej\u00eda-Granados DM, Villasana-Salazar B, Lozano-Garc\u00eda L, Cavalheiro EA, Striano P (2021) Gut-microbiota-directed strategies to treat epilepsy: clinical and experimental evidence. Seizure 90:80\u201392. https:\/\/doi.org\/10.1016\/j.seizure.2021.03.009","journal-title":"Seizure"},{"key":"6227_CR26","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/s41522-018-0073-2","volume":"5","author":"M Lindefeldt","year":"2019","unstructured":"Lindefeldt M, Eng A, Darban H, Bjerkner A, Zetterstr\u00f6m CK, Allander T, Andersson B, Borenstein E et al (2019) The ketogenic diet influences taxonomic and functional composition of the gut microbiota in children with severe epilepsy. npj Biofilms Microbiomes 5:5. https:\/\/doi.org\/10.1038\/s41522-018-0073-2","journal-title":"npj Biofilms Microbiomes"},{"key":"6227_CR27","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1038\/nrn3346","volume":"13","author":"JF Cryan","year":"2012","unstructured":"Cryan JF, Dinan TG (2012) Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour. Nat Rev Neurosci 13:701\u2013712. https:\/\/doi.org\/10.1038\/nrn3346","journal-title":"Nat Rev Neurosci"},{"key":"6227_CR28","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.1016\/j.cell.2018.04.027","volume":"173","author":"CA Olson","year":"2018","unstructured":"Olson CA, Vuong HE, Yano JM, Liang QY, Nusbaum DJ, Hsiao EY (2018) The gut microbiota mediates the anti-seizure effects of the ketogenic diet. Cell 173:1728-1741.e13. https:\/\/doi.org\/10.1016\/j.cell.2018.04.027","journal-title":"Cell"},{"key":"6227_CR29","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.jcmgh.2018.04.003","volume":"6","author":"CR Martin","year":"2018","unstructured":"Martin CR, Osadchiy V, Kalani A, Mayer EA (2018) The brain-gut-microbiome axis. Cell Mol Gastroenterol Hepatol 6:133\u2013148. https:\/\/doi.org\/10.1016\/j.jcmgh.2018.04.003","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"6227_CR30","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1111\/hir.12295","volume":"38","author":"P Kokol","year":"2021","unstructured":"Kokol P, Bla\u017eun Vo\u0161ner H, Zavr\u0161nik J (2021) Application of bibliometrics in medicine: a historical bibliometrics analysis. Health Info Libr J 38:125\u2013138. https:\/\/doi.org\/10.1111\/hir.12295","journal-title":"Health Info Libr J"},{"key":"6227_CR31","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1007\/s00381-020-04897-9","volume":"37","author":"MG Kutluk","year":"2021","unstructured":"Kutluk MG, Danis A (2021) Bibliometric analysis of publications on pediatric epilepsy between 1980 and 2018. Childs Nerv Syst 37:617\u2013626. https:\/\/doi.org\/10.1007\/s00381-020-04897-9","journal-title":"Childs Nerv Syst"},{"key":"6227_CR32","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.jbusres.2021.04.070","volume":"133","author":"N Donthu","year":"2021","unstructured":"Donthu N, Kumar S, Mukherjee D, Pandey N, Lim WM (2021) How to conduct a bibliometric analysis: an overview and guidelines. J Bus Res 133:285\u2013296. https:\/\/doi.org\/10.1016\/j.jbusres.2021.04.070","journal-title":"J Bus Res"},{"key":"6227_CR33","doi-asserted-by":"publisher","first-page":"1506566","DOI":"10.3389\/fnins.2025.1506566","volume":"19","author":"L Chen","year":"2025","unstructured":"Chen L, Wu L-L, Yu C-Y, Xu Z-C, Huang H (2025) Bibliometric analysis of the intestinal microbiota and demyelinating diseases, particularly multiple sclerosis, since 2014. Front Neurosci 19:1506566. https:\/\/doi.org\/10.3389\/fnins.2025.1506566","journal-title":"Front Neurosci"},{"key":"6227_CR34","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1093\/procel\/pwad026","volume":"14","author":"Q Wang","year":"2023","unstructured":"Wang Q, Yang Q, Liu X (2023) The microbiota\u2013gut\u2013brain axis and neurodevelopmental disorders. Protein Cell 14:762\u2013775. https:\/\/doi.org\/10.1093\/procel\/pwad026","journal-title":"Protein Cell"},{"key":"6227_CR35","doi-asserted-by":"publisher","DOI":"10.12659\/MSM.936037","volume":"28","author":"H Wang","year":"2022","unstructured":"Wang H, Long T, You J, Li P, Xu Q (2022) Bibliometric visualization analysis of microbiome-gut-brain axis from 2004 to 2020. Med Sci Monit 28:e936037. https:\/\/doi.org\/10.12659\/MSM.936037","journal-title":"Med Sci Monit"},{"key":"6227_CR36","doi-asserted-by":"publisher","DOI":"10.3145\/epi.2020.ene.03","volume":"29","author":"JA Moral-Mu\u00f1oz","year":"2020","unstructured":"Moral-Mu\u00f1oz JA, Herrera-Viedma E, Santisteban-Espejo A, Cobo MJ (2020) Software tools for conducting bibliometric analysis in science: an up-to-date review. Profesional de la Informacion 29:e290103. https:\/\/doi.org\/10.3145\/epi.2020.ene.03","journal-title":"Profesional de la Informacion"},{"key":"6227_CR37","doi-asserted-by":"publisher","first-page":"2562","DOI":"10.3390\/healthcare10122562","volume":"10","author":"H Ejaz","year":"2022","unstructured":"Ejaz H, Zeeshan HM, Iqbal A, Ahmad S, Ahmad F, Abdalla AE, Anwar N, Junaid K et al (2022) Rubella virus infections: a bibliometric analysis of the scientific literature from 2000 to 2021. Healthcare (Basel) 10:2562. https:\/\/doi.org\/10.3390\/healthcare10122562","journal-title":"Healthcare (Basel)"},{"key":"6227_CR38","doi-asserted-by":"publisher","first-page":"12407","DOI":"10.3390\/ijerph191912407","volume":"19","author":"H Ejaz","year":"2022","unstructured":"Ejaz H, Zeeshan HM, Ahmad F, Bukhari SNA, Anwar N, Alanazi A, Sadiq A, Junaid K et al (2022) Bibliometric analysis of publications on the Omicron variant from 2020 to 2022 in the Scopus database using R and VOSviewer. Int J Environ Res Public Health 19:12407. https:\/\/doi.org\/10.3390\/ijerph191912407","journal-title":"Int J Environ Res Public Health"},{"key":"6227_CR39","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1007\/s10778-009-0189-4","volume":"45","author":"AN Guz","year":"2009","unstructured":"Guz AN, Rushchitsky JJ (2009) Scopus: a system for the evaluation of scientific journals. Int Appl Mech 45:351\u2013362. https:\/\/doi.org\/10.1007\/s10778-009-0189-4","journal-title":"Int Appl Mech"},{"key":"6227_CR40","doi-asserted-by":"publisher","first-page":"2623","DOI":"10.1096\/fj.08-107938","volume":"22","author":"ME Falagas","year":"2008","unstructured":"Falagas ME, Kouranos VD, Arencibia-Jorge R, Karageorgopoulos DE (2008) Comparison of SCImago journal rank indicator with journal impact factor. FASEB J 22:2623\u20132628. https:\/\/doi.org\/10.1096\/fj.08-107938","journal-title":"FASEB J"},{"key":"6227_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.dr.2022.101038","volume":"66","author":"K Vaher","year":"2022","unstructured":"Vaher K, Bogaert D, Richardson H, Boardman JP (2022) Microbiome-gut-brain axis in brain development, cognition and behavior during infancy and early childhood. Dev Rev 66:101038. https:\/\/doi.org\/10.1016\/j.dr.2022.101038","journal-title":"Dev Rev"},{"key":"6227_CR42","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1021\/acschemneuro.3c00127","volume":"14","author":"JM Sasso","year":"2023","unstructured":"Sasso JM, Ammar RM, Tenchov R, Lemmel S, Kelber O, Grieswelle M, Zhou QA (2023) Gut microbiome\u2013brain alliance: a landscape view into mental and gastrointestinal health and disorders. ACS Chem Neurosci 14:1717\u20131763. https:\/\/doi.org\/10.1021\/acschemneuro.3c00127","journal-title":"ACS Chem Neurosci"},{"key":"6227_CR43","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2021.753915","volume":"15","author":"G Deidda","year":"2021","unstructured":"Deidda G, Biazzo M (2021) Gut and brain: investigating physiological and pathological interactions between microbiota and brain to gain new therapeutic avenues for brain diseases. Front Neurosci 15:753915. https:\/\/doi.org\/10.3389\/fnins.2021.753915","journal-title":"Front Neurosci"},{"key":"6227_CR44","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2021.1894070","volume":"13","author":"X Qi","year":"2021","unstructured":"Qi X, Yun C, Pang Y, Qiao J (2021) The impact of the gut microbiota on the reproductive and metabolic endocrine system. Gut Microbes 13:1894070. https:\/\/doi.org\/10.1080\/19490976.2021.1894070","journal-title":"Gut Microbes"},{"key":"6227_CR45","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.1007\/s10482-020-01474-7","volume":"113","author":"EZ Gomaa","year":"2020","unstructured":"Gomaa EZ (2020) Human gut microbiota\/microbiome in health and diseases: a review. Antonie Van Leeuwenhoek 113:2019\u20132040. https:\/\/doi.org\/10.1007\/s10482-020-01474-7","journal-title":"Antonie Van Leeuwenhoek"},{"key":"6227_CR46","doi-asserted-by":"publisher","first-page":"4631","DOI":"10.3390\/nu15214631","volume":"15","author":"Y Zheng","year":"2023","unstructured":"Zheng Y, Bonfili L, Wei T, Eleuteri AM (2023) Understanding the gut\u2013brain axis and its therapeutic implications for neurodegenerative disorders. Nutrients 15:4631. https:\/\/doi.org\/10.3390\/nu15214631","journal-title":"Nutrients"},{"key":"6227_CR47","doi-asserted-by":"publisher","first-page":"15389","DOI":"10.3390\/ijms232315389","volume":"23","author":"F Muhammad","year":"2022","unstructured":"Muhammad F, Fan B, Wang R, Ren J, Jia S, Wang L, Chen Z, Liu X-A (2022) The molecular gut-brain axis in early brain development. Int J Mol Sci 23:15389. https:\/\/doi.org\/10.3390\/ijms232315389","journal-title":"Int J Mol Sci"},{"key":"6227_CR48","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/978-1-4939-0897-4_3","volume":"817","author":"JB Furness","year":"2014","unstructured":"Furness JB, Callaghan BP, Rivera LR, Cho H-J (2014) The enteric nervous system and gastrointestinal innervation: integrated local and central control. Adv Exp Med Biol 817:39\u201371. https:\/\/doi.org\/10.1007\/978-1-4939-0897-4_3","journal-title":"Adv Exp Med Biol"},{"key":"6227_CR49","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2021.108721","volume":"197","author":"S Fried","year":"2021","unstructured":"Fried S, Wemelle E, Cani PD, Knauf C (2021) Interactions between the microbiota and enteric nervous system during gut-brain disorders. Neuropharmacology 197:108721. https:\/\/doi.org\/10.1016\/j.neuropharm.2021.108721","journal-title":"Neuropharmacology"},{"key":"6227_CR50","doi-asserted-by":"publisher","first-page":"3705","DOI":"10.3390\/jcm9113705","volume":"9","author":"M Giuffr\u00e8","year":"2020","unstructured":"Giuffr\u00e8 M, Moretti R, Campisciano G, da Silveira ABM, Monda VM, Comar M, Di Bella S, Antonello RM et al (2020) You talking to me? Says the enteric nervous system (ENS) to the microbe. How intestinal microbes interact with the ENS. J Clin Med 9:3705. https:\/\/doi.org\/10.3390\/jcm9113705","journal-title":"J Clin Med"},{"key":"6227_CR51","doi-asserted-by":"publisher","DOI":"10.3389\/fmedt.2021.696543","volume":"3","author":"P Afra","year":"2021","unstructured":"Afra P, Adamolekun B, Aydemir S, Watson G (2021) Evolution of the vagus nerve stimulation (VNS) therapy system technology for drug-resistant epilepsy. Front Med Technol 3:696543. https:\/\/doi.org\/10.3389\/fmedt.2021.696543","journal-title":"Front Med Technol"},{"key":"6227_CR52","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1038\/s41522-024-00477-w","volume":"10","author":"T-T Lai","year":"2024","unstructured":"Lai T-T, Tsai Y-H, Liou C-W, Fan C-H, Hou Y-T, Yao T-H, Chuang H-L, Wu W-L (2024) The gut microbiota modulate locomotion via vagus-dependent glucagon-like peptide-1 signaling. npj Biofilms Microbiomes 10:2. https:\/\/doi.org\/10.1038\/s41522-024-00477-w","journal-title":"npj Biofilms Microbiomes"},{"key":"6227_CR53","doi-asserted-by":"publisher","first-page":"3002","DOI":"10.1038\/s41380-023-02071-6","volume":"28","author":"E Siopi","year":"2023","unstructured":"Siopi E, Galerne M, Rivagorda M, Saha S, Moigneu C, Moriceau S, Bigot M, Oury F et al (2023) Gut microbiota changes require vagus nerve integrity to promote depressive-like behaviors in mice. Mol Psychiatry 28:3002\u20133012. https:\/\/doi.org\/10.1038\/s41380-023-02071-6","journal-title":"Mol Psychiatry"},{"key":"6227_CR54","doi-asserted-by":"publisher","first-page":"111699","DOI":"10.1016\/j.isci.2024.111699","volume":"28","author":"KG Jameson","year":"2025","unstructured":"Jameson KG, Kazmi SA, Ohara TE, Son C, Yu KB, Mazdeyasnan D, Leshan E, Vuong HE et al (2025) Select microbial metabolites in the small intestinal lumen regulate vagal activity via receptor-mediated signaling. iScience 28:111699. https:\/\/doi.org\/10.1016\/j.isci.2024.111699","journal-title":"iScience"},{"key":"6227_CR55","doi-asserted-by":"publisher","first-page":"101350","DOI":"10.1016\/j.molmet.2021.101350","volume":"54","author":"TM Cook","year":"2021","unstructured":"Cook TM, Gavini CK, Jesse J, Aubert G, Gornick E, Bonomo R, Gautron L, Layden BT et al (2021) Vagal neuron expression of the microbiota-derived metabolite receptor, free fatty acid receptor (FFAR3), is necessary for normal feeding behavior. Mol Metab 54:101350. https:\/\/doi.org\/10.1016\/j.molmet.2021.101350","journal-title":"Mol Metab"},{"key":"6227_CR56","doi-asserted-by":"publisher","first-page":"16050","DOI":"10.1073\/pnas.1102999108","volume":"108","author":"JA Bravo","year":"2011","unstructured":"Bravo JA, Forsythe P, Chew MV, Escaravage E, Savignac HM, Dinan TG, Bienenstock J, Cryan JF (2011) Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve. Proc Natl Acad Sci U S A 108:16050\u201316055. https:\/\/doi.org\/10.1073\/pnas.1102999108","journal-title":"Proc Natl Acad Sci U S A"},{"key":"6227_CR57","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.phrs.2014.12.001","volume":"93","author":"M Auteri","year":"2015","unstructured":"Auteri M, Zizzo MG, Serio R (2015) GABA and GABA receptors in the gastrointestinal tract: from motility to inflammation. Pharmacol Res 93:11\u201321. https:\/\/doi.org\/10.1016\/j.phrs.2014.12.001","journal-title":"Pharmacol Res"},{"key":"6227_CR58","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1111\/j.1528-1157.1999.tb00818.x","volume":"40","author":"BR Walker","year":"1999","unstructured":"Walker BR, Easton A, Gale K (1999) Regulation of limbic motor seizures by GABA and glutamate transmission in nucleus tractus solitarius. Epilepsia 40:1051\u20131057. https:\/\/doi.org\/10.1111\/j.1528-1157.1999.tb00818.x","journal-title":"Epilepsia"},{"key":"6227_CR59","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/nn.4476","volume":"20","author":"TC Fung","year":"2017","unstructured":"Fung TC, Olson CA, Hsiao EY (2017) Interactions between the microbiota, immune and nervous systems in health and disease. Nat Neurosci 20:145\u2013155. https:\/\/doi.org\/10.1038\/nn.4476","journal-title":"Nat Neurosci"},{"key":"6227_CR60","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1186\/s12974-022-02510-1","volume":"19","author":"P Sittipo","year":"2022","unstructured":"Sittipo P, Choi J, Lee S, Lee YK (2022) The function of gut microbiota in immune-related neurological disorders: a review. J Neuroinflammation 19:154. https:\/\/doi.org\/10.1186\/s12974-022-02510-1","journal-title":"J Neuroinflammation"},{"key":"6227_CR61","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/j.pbj.0000000000000059","volume":"5","author":"C Almeida","year":"2020","unstructured":"Almeida C, Oliveira R, Soares R, Barata P (2020) Influence of gut microbiota dysbiosis on brain function: a systematic review. Porto Biomed J 5:1\u20138. https:\/\/doi.org\/10.1097\/j.pbj.0000000000000059","journal-title":"Porto Biomed J"},{"key":"6227_CR62","doi-asserted-by":"publisher","first-page":"7551","DOI":"10.3390\/ijms21207551","volume":"21","author":"K Suganya","year":"2020","unstructured":"Suganya K, Koo B-S (2020) Gut\u2013brain axis: role of gut microbiota on neurological disorders and how probiotics\/prebiotics beneficially modulate microbial and immune pathways to improve brain functions. Int J Mol Sci 21:7551. https:\/\/doi.org\/10.3390\/ijms21207551","journal-title":"Int J Mol Sci"},{"key":"6227_CR63","doi-asserted-by":"publisher","first-page":"1","DOI":"10.14785\/lymphosign-2019-0018","volume":"7","author":"E Salvo-Romero","year":"2020","unstructured":"Salvo-Romero E, Stokes P, Gareau MG (2020) Microbiota-immune interactions: from gut to brain. LymphoSign J 7:1\u201323. https:\/\/doi.org\/10.14785\/lymphosign-2019-0018","journal-title":"LymphoSign J"},{"key":"6227_CR64","doi-asserted-by":"publisher","first-page":"111572","DOI":"10.1016\/j.mce.2022.111572","volume":"546","author":"KJ O'Riordan","year":"2022","unstructured":"O\u2019Riordan KJ, Collins MK, Moloney GM, Knox EG, Aburto MR, F\u00fclling C, Morley SJ, Clarke G et al (2022) Short chain fatty acids: microbial metabolites for gut-brain axis signalling. Mol Cell Endocrinol 546:111572. https:\/\/doi.org\/10.1016\/j.mce.2022.111572","journal-title":"Mol Cell Endocrinol"},{"key":"6227_CR65","unstructured":"Miralles Solsona R (2021) Impact of the short-chain fatty acids on the microbiota-gut-brain axis. Bachelor's thesis, University of Barcelona. https:\/\/hdl.handle.net\/2445\/179149. Accessed 2 September 2026"},{"key":"6227_CR66","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3389\/fendo.2020.00025","volume":"11","author":"YP Silva","year":"2020","unstructured":"Silva YP, Bernardi A, Frozza RL (2020) The role of short-chain fatty acids from gut microbiota in gut-brain communication. Front Endocrinol 11:25. https:\/\/doi.org\/10.3389\/fendo.2020.00025","journal-title":"Front Endocrinol"},{"key":"6227_CR67","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1007\/s10571-024-01496-z","volume":"44","author":"R Kearns","year":"2024","unstructured":"Kearns R (2024) Gut\u2013brain axis and neuroinflammation: the role of gut permeability and the kynurenine pathway in neurological disorders. Cell Mol Neurobiol 44:64. https:\/\/doi.org\/10.1007\/s10571-024-01496-z","journal-title":"Cell Mol Neurobiol"},{"key":"6227_CR68","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1038\/s41401-025-01743-z","volume":"47","author":"MA Rakib","year":"2026","unstructured":"Rakib MA, Cho EB, Yasmen N, Jiang C, Aktaruzzaman M, Han J, Yu Y, Jiang J (2026) Status epilepticus-induced 12\/15-lipoxygenase drives neuroinflammation and contributes to neuronal injuries and behavioral comorbidities. Acta Pharmacol Sin 47:1471\u20131487. https:\/\/doi.org\/10.1038\/s41401-025-01743-z","journal-title":"Acta Pharmacol Sin"},{"key":"6227_CR69","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbr.2023.114459","volume":"448","author":"J Wasiak","year":"2023","unstructured":"Wasiak J, Gawlik-Kotelnicka O (2023) Intestinal permeability and its significance in psychiatric disorders\u2013a narrative review and future perspectives. Behav Brain Res 448:114459. https:\/\/doi.org\/10.1016\/j.bbr.2023.114459","journal-title":"Behav Brain Res"},{"key":"6227_CR70","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.604179","volume":"11","author":"A Rutsch","year":"2020","unstructured":"Rutsch A, Kantsj\u00f6 J, Ronchi F (2020) The gut-brain axis: how microbiota and host inflammasome influence brain physiology and pathology. Front Immunol 11:604179. https:\/\/doi.org\/10.3389\/fimmu.2020.604179","journal-title":"Front Immunol"},{"key":"6227_CR71","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-99805-z","volume":"15","author":"K Chojnowski","year":"2025","unstructured":"Chojnowski K, Opie\u0142ka M, Urbanowicz K, Zawadzka M, Wangin K, Smole\u0144ski RT, Mazurkiewicz-Be\u0142dzi\u0144ska M (2025) Untargeted metabolomics reveals key metabolic alterations in pediatric epilepsy with insights into tryptophan metabolism and the gut\u2013brain axis. Sci Rep 15:15262. https:\/\/doi.org\/10.1038\/s41598-025-99805-z","journal-title":"Sci Rep"},{"key":"6227_CR72","doi-asserted-by":"publisher","DOI":"10.3390\/cells13171436","volume":"13","author":"A Verma","year":"2024","unstructured":"Verma A, Inslicht SS, Bhargava A (2024) Gut-brain axis: role of microbiome, metabolomics, hormones, and stress in mental health disorders. Cells 13:1436. https:\/\/doi.org\/10.3390\/cells13171436","journal-title":"Cells"},{"key":"6227_CR73","doi-asserted-by":"publisher","first-page":"105640","DOI":"10.1016\/j.psyneuen.2021.105640","volume":"137","author":"C Barrio","year":"2022","unstructured":"Barrio C, Arias-S\u00e1nchez S, Mart\u00edn-Monz\u00f3n I (2022) The gut microbiota-brain axis, psychobiotics and its influence on brain and behaviour: A systematic review. Psychoneuroendocrinology 137:105640. https:\/\/doi.org\/10.1016\/j.psyneuen.2021.105640","journal-title":"Psychoneuroendocrinology"},{"key":"6227_CR74","doi-asserted-by":"publisher","DOI":"10.1016\/j.psyneuen.2019.104501","volume":"111","author":"A Labanski","year":"2020","unstructured":"Labanski A, Langhorst J, Engler H, Elsenbruch S (2020) Stress and the brain-gut axis in functional and chronic-inflammatory gastrointestinal diseases: a transdisciplinary challenge. Psychoneuroendocrinology 111:104501. https:\/\/doi.org\/10.1016\/j.psyneuen.2019.104501","journal-title":"Psychoneuroendocrinology"},{"key":"6227_CR75","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.ynstr.2017.03.001","volume":"7","author":"JA Foster","year":"2017","unstructured":"Foster JA, Rinaman L, Cryan JF (2017) Stress & the gut-brain axis: regulation by the microbiome. Neurobiol Stress 7:124\u2013136. https:\/\/doi.org\/10.1016\/j.ynstr.2017.03.001","journal-title":"Neurobiol Stress"},{"key":"6227_CR76","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.neuint.2016.06.011","volume":"99","author":"RM Stilling","year":"2016","unstructured":"Stilling RM, Van De Wouw M, Clarke G, Stanton C, Dinan TG, Cryan JF (2016) The neuropharmacology of butyrate: the bread and butter of the microbiota-gut-brain axis? Neurochem Int 99:110\u2013132. https:\/\/doi.org\/10.1016\/j.neuint.2016.06.011","journal-title":"Neurochem Int"},{"key":"6227_CR77","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2020.110112","volume":"106","author":"D Goyal","year":"2021","unstructured":"Goyal D, Ali SA, Singh RK (2021) Emerging role of gut microbiota in modulation of neuroinflammation and neurodegeneration with emphasis on Alzheimer\u2019s disease. Prog Neuropsychopharmacol Biol Psychiatry 106:110112. https:\/\/doi.org\/10.1016\/j.pnpbp.2020.110112","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"6227_CR78","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1111\/febs.17023","volume":"292","author":"T Sampson","year":"2025","unstructured":"Sampson T (2025) Microbial amyloids in neurodegenerative amyloid diseases. FEBS J 292:1265\u20131281. https:\/\/doi.org\/10.1111\/febs.17023","journal-title":"FEBS J"},{"key":"6227_CR79","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1016\/j.tins.2016.09.002","volume":"39","author":"A Sarkar","year":"2016","unstructured":"Sarkar A, Lehto SM, Harty S, Dinan TG, Cryan JF, Burnet PW (2016) Psychobiotics and the manipulation of bacteria\u2013gut\u2013brain signals. Trends Neurosci 39:763\u2013781. https:\/\/doi.org\/10.1016\/j.tins.2016.09.002","journal-title":"Trends Neurosci"},{"key":"6227_CR80","doi-asserted-by":"publisher","first-page":"9410","DOI":"10.1038\/s41467-024-53279-1","volume":"15","author":"N De Langhe","year":"2024","unstructured":"De Langhe N, Van Dorpe S, Guilbert N, Vander Cruyssen A, Roux Q, Deville S, Dedeyne S, Tummers P et al (2024) Mapping bacterial extracellular vesicle research: insights, best practices and knowledge gaps. Nat Commun 15:9410. https:\/\/doi.org\/10.1038\/s41467-024-53279-1","journal-title":"Nat Commun"},{"key":"6227_CR81","doi-asserted-by":"publisher","first-page":"15297","DOI":"10.1038\/s41598-017-15717-7","volume":"7","author":"BJ Benedikter","year":"2017","unstructured":"Benedikter BJ, Bouwman FG, Vajen T, Heinzmann AC, Grauls G, Mariman EC, Wouters EF, Savelkoul PH et al (2017) Ultrafiltration combined with size exclusion chromatography efficiently isolates extracellular vesicles from cell culture media for compositional and functional studies. Sci Rep 7:15297. https:\/\/doi.org\/10.1038\/s41598-017-15717-7","journal-title":"Sci Rep"},{"key":"6227_CR82","doi-asserted-by":"publisher","first-page":"e450","DOI":"10.1038\/emm.2017.282","volume":"50","author":"C Chelakkot","year":"2018","unstructured":"Chelakkot C, Choi Y, Kim DK, Park HT, Ghim J, Kwon Y, Jeon J, Kim MS et al (2018) Akkermansia muciniphila-derived extracellular vesicles influence gut permeability through the regulation of tight junctions. Exp Mol Med 50:e450. https:\/\/doi.org\/10.1038\/emm.2017.282","journal-title":"Exp Mol Med"},{"key":"6227_CR83","doi-asserted-by":"publisher","first-page":"3535","DOI":"10.1038\/s41467-025-58676-8","volume":"16","author":"Q Li","year":"2025","unstructured":"Li Q, Ou Z, Lin J, Tang D, He B, Wu Y, Huang X, Huang X et al (2025) Specific labeling of outer membrane vesicles with antibiotic-conjugated probe reveals early bacterial infections in blood. Nat Commun 16:3535. https:\/\/doi.org\/10.1038\/s41467-025-58676-8","journal-title":"Nat Commun"},{"key":"6227_CR84","doi-asserted-by":"publisher","first-page":"15125","DOI":"10.1038\/s41598-020-72242-w","volume":"10","author":"J-H Lee","year":"2020","unstructured":"Lee J-H, Choi J-P, Yang J, Won H-K, Park CS, Song W-J, Kwon H-S, Kim T-B et al (2020) Metagenome analysis using serum extracellular vesicles identified distinct microbiota in asthmatics. Sci Rep 10:15125. https:\/\/doi.org\/10.1038\/s41598-020-72242-w","journal-title":"Sci Rep"},{"key":"6227_CR85","doi-asserted-by":"publisher","first-page":"7044","DOI":"10.1038\/s41467-025-62220-z","volume":"16","author":"W Guo","year":"2025","unstructured":"Guo W, Kaczmarczyk I, Kopietz K, Flegler F, Russo S, Cigirgan E, Chramiec-G\u0142\u0105bik A, Koziej \u0141 et al (2025) Queuosine is incorporated into precursor tRNA before splicing. Nat Commun 16:7044. https:\/\/doi.org\/10.1038\/s41467-025-62220-z","journal-title":"Nat Commun"},{"key":"6227_CR86","doi-asserted-by":"publisher","first-page":"1862","DOI":"10.1038\/s41467-025-57153-6","volume":"16","author":"X Gong","year":"2025","unstructured":"Gong X, Liu S, Xia B, Wan Y, Zhang S, Zhang B, Wang Z, Chen J et al (2025) Oral delivery of therapeutic proteins by engineered bacterial type zero secretion system. Nat Commun 16:1862. https:\/\/doi.org\/10.1038\/s41467-025-57153-6","journal-title":"Nat Commun"},{"key":"6227_CR87","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1038\/s41467-025-56091-7","volume":"16","author":"E \u00d6zcan","year":"2025","unstructured":"\u00d6zcan E, Yu KB, Dinh L, Lum GR, Lau K, Hsu J, Arino M, Paramo J et al (2025) Dietary fiber content in clinical ketogenic diets modifies the gut microbiome and seizure resistance in mice. Nat Commun 16:987. https:\/\/doi.org\/10.1038\/s41467-025-56091-7","journal-title":"Nat Commun"},{"key":"6227_CR88","doi-asserted-by":"publisher","DOI":"10.1080\/21505594.2025.2541704","volume":"16","author":"T Zhang","year":"2025","unstructured":"Zhang T, Guo F, Zhang C, Xiang Y (2025) Decoding the role of gut mycobiota in immune regulation and disease. Virulence 16:2541704. https:\/\/doi.org\/10.1080\/21505594.2025.2541704","journal-title":"Virulence"},{"key":"6227_CR89","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/j.chom.2019.05.010","volume":"25","author":"JJ Barr","year":"2019","unstructured":"Barr JJ (2019) Precision engineers: bacteriophages modulate the gut microbiome and metabolome. Cell Host Microbe 25:771\u2013773. https:\/\/doi.org\/10.1016\/j.chom.2019.05.010","journal-title":"Cell Host Microbe"},{"key":"6227_CR90","doi-asserted-by":"publisher","DOI":"10.1186\/s40168-023-01565-3","volume":"11","author":"A Campbell","year":"2023","unstructured":"Campbell A, Gdanetz K, Schmidt AW, Schmidt TM (2023) H2 generated by fermentation in the human gut microbiome influences metabolism and competitive fitness of gut butyrate producers. Microbiome 11:133. https:\/\/doi.org\/10.1186\/s40168-023-01565-3","journal-title":"Microbiome"},{"key":"6227_CR91","doi-asserted-by":"publisher","first-page":"2628","DOI":"10.3390\/microorganisms11112628","volume":"11","author":"K Zhou","year":"2023","unstructured":"Zhou K, Jia L, Mao Z, Si P, Sun C, Qu Z, Wang W (2023) Integrated macrogenomics and metabolomics explore alterations and correlation between gut microbiota and serum metabolites in adult epileptic patients: a pilot study. Microorganisms 11:2628. https:\/\/doi.org\/10.3390\/microorganisms11112628","journal-title":"Microorganisms"},{"key":"6227_CR92","doi-asserted-by":"publisher","first-page":"105614","DOI":"10.1016\/j.nbd.2022.105614","volume":"164","author":"L Boeri","year":"2022","unstructured":"Boeri L, Donnaloja F, Campanile M, Sardelli L, Tunesi M, Fusco F, Giordano C, Albani D (2022) Using integrated meta-omics to appreciate the role of the gut microbiota in epilepsy. Neurobiol Dis 164:105614. https:\/\/doi.org\/10.1016\/j.nbd.2022.105614","journal-title":"Neurobiol Dis"},{"key":"6227_CR93","doi-asserted-by":"publisher","first-page":"113521","DOI":"10.1016\/j.celrep.2023.113521","volume":"42","author":"GR Lum","year":"2023","unstructured":"Lum GR, Ha SM, Olson CA, Blencowe M, Paramo J, Reyes B, Matsumoto JH, Yang X et al (2023) Ketogenic diet therapy for pediatric epilepsy is associated with alterations in the human gut microbiome that confer seizure resistance in mice. Cell Rep 42:113521. https:\/\/doi.org\/10.1016\/j.celrep.2023.113521","journal-title":"Cell Rep"},{"key":"6227_CR94","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2022.103833","volume":"76","author":"C Mu","year":"2022","unstructured":"Mu C, Choudhary A, Mayengbam S, Barrett KT, Rho JM, Shearer J, Scantlebury MH (2022) Seizure modulation by the gut microbiota and tryptophan-kynurenine metabolism in an animal model of infantile spasms. EBioMedicine 76:103833. https:\/\/doi.org\/10.1016\/j.ebiom.2022.103833","journal-title":"EBioMedicine"},{"key":"6227_CR95","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s13059-017-1215-1","volume":"18","author":"Y Hasin","year":"2017","unstructured":"Hasin Y, Seldin M, Lusis A (2017) Multi-omics approaches to disease. Genome Biol 18:83. https:\/\/doi.org\/10.1186\/s13059-017-1215-1","journal-title":"Genome Biol"},{"key":"6227_CR96","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1038\/s41586-019-1237-9","volume":"569","author":"J Lloyd-Price","year":"2019","unstructured":"Lloyd-Price J, Arze C, Ananthakrishnan AN, Schirmer M, Avila-Pacheco J, Poon TW, Andrews E, Ajami NJ et al (2019) Multi-omics of the gut microbial ecosystem in inflammatory bowel diseases. Nature 569:655\u2013662. https:\/\/doi.org\/10.1038\/s41586-019-1237-9","journal-title":"Nature"},{"key":"6227_CR97","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s12974-019-1434-3","volume":"16","author":"Q Ma","year":"2019","unstructured":"Ma Q, Xing C, Long W, Wang HY, Liu Q, Wang R-F (2019) Impact of microbiota on central nervous system and neurological diseases: the gut-brain axis. J Neuroinflammation 16:53. https:\/\/doi.org\/10.1186\/s12974-019-1434-3","journal-title":"J Neuroinflammation"},{"key":"6227_CR98","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/S1474-4422(19)30356-4","volume":"19","author":"JF Cryan","year":"2020","unstructured":"Cryan JF, O\u2019Riordan KJ, Sandhu K, Peterson V, Dinan TG (2020) The gut microbiome in neurological disorders. Lancet Neurol 19:179\u2013194. https:\/\/doi.org\/10.1016\/S1474-4422(19)30356-4","journal-title":"Lancet Neurol"},{"key":"6227_CR99","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1038\/mp.2016.44","volume":"21","author":"P Zheng","year":"2016","unstructured":"Zheng P, Zeng B, Zhou C, Liu M, Fang Z, Xu X, Zeng L, Chen J et al (2016) Gut microbiome remodeling induces depressive-like behaviors through a pathway mediated by the host\u2019s metabolism. Mol Psychiatry 21:786\u2013796. https:\/\/doi.org\/10.1038\/mp.2016.44","journal-title":"Mol Psychiatry"},{"key":"6227_CR100","doi-asserted-by":"publisher","first-page":"14519","DOI":"10.1007\/s12035-025-04993-4","volume":"62","author":"P Shirzadi","year":"2025","unstructured":"Shirzadi P, Farokh P, Osouli Meinagh S, Izadi-Jorshari G, Hajikarimloo B, Mohammadi G, Parvardeh S, Nassiri-Asl M (2025) The influence of probiotics, ketogenic diets, and gut microbiota on epilepsy and epileptic models: a comprehensive review. Mol Neurobiol 62:14519\u201314543. https:\/\/doi.org\/10.1007\/s12035-025-04993-4","journal-title":"Mol Neurobiol"},{"key":"6227_CR101","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.3748\/wjg.v28.i18.1875","volume":"28","author":"NK Saeed","year":"2022","unstructured":"Saeed NK, Al-Beltagi M, Bediwy AS, El-Sawaf Y, Toema O (2022) Gut microbiota in various childhood disorders: implication and indications. World J Gastroenterol 28:1875\u20131901. https:\/\/doi.org\/10.3748\/wjg.v28.i18.1875","journal-title":"World J Gastroenterol"},{"key":"6227_CR102","doi-asserted-by":"publisher","first-page":"2268","DOI":"10.1111\/epi.18367","volume":"66","author":"A Riva","year":"2025","unstructured":"Riva A, Sahin E, Volpedo G, Catania NT, Venara I, Biagioli V, Balagura G, Amadori E et al (2025) Medication-resistant epilepsy is associated with a unique gut microbiota signature. Epilepsia 66:2268\u20132284. https:\/\/doi.org\/10.1111\/epi.18367","journal-title":"Epilepsia"},{"key":"6227_CR103","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.eplepsyres.2018.09.013","volume":"147","author":"A Peng","year":"2018","unstructured":"Peng A, Qiu X, Lai W, Li W, Zhang L, Zhu X, He S, Duan J et al (2018) Altered composition of the gut microbiome in patients with drug-resistant epilepsy. Epilepsy Res 147:102\u2013107. https:\/\/doi.org\/10.1016\/j.eplepsyres.2018.09.013","journal-title":"Epilepsy Res"},{"key":"6227_CR104","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.jocn.2024.01.023","volume":"120","author":"R Yang","year":"2024","unstructured":"Yang R, Liu J, Diao L, Wei L, Luo H, Cai L (2024) A meta-analysis of the changes in the gut microbiota in patients with intractable epilepsy compared to healthy controls. J Clin Neurosci 120:213\u2013220. https:\/\/doi.org\/10.1016\/j.jocn.2024.01.023","journal-title":"J Clin Neurosci"},{"key":"6227_CR105","doi-asserted-by":"publisher","first-page":"749509","DOI":"10.3389\/fcimb.2021.749509","volume":"11","author":"C Ceccarani","year":"2021","unstructured":"Ceccarani C, Vigan\u00f2 I, Ottaviano E, Redaelli MG, Severgnini M, Vignoli A, Borghi E (2021) Is gut microbiota a key player in epilepsy onset? A longitudinal study in drug-naive children. Front Cell Infect Microbiol 11:749509. https:\/\/doi.org\/10.3389\/fcimb.2021.749509","journal-title":"Front Cell Infect Microbiol"},{"key":"6227_CR106","doi-asserted-by":"publisher","DOI":"10.1016\/j.micpath.2019.103853","volume":"139","author":"B \u015eafak","year":"2020","unstructured":"\u015eafak B, Altunan B, Top\u00e7u B, Topkaya AE (2020) The gut microbiome in epilepsy. Microb Pathog 139:103853. https:\/\/doi.org\/10.1016\/j.micpath.2019.103853","journal-title":"Microb Pathog"},{"key":"6227_CR107","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3389\/fped.2019.00394","volume":"7","author":"C Huang","year":"2019","unstructured":"Huang C, Li Y, Feng X, Li D, Li X, Ouyang Q, Dai W, Wu G et al (2019) Distinct gut microbiota composition and functional category in children with cerebral palsy and epilepsy. Front Pediatr 7:394. https:\/\/doi.org\/10.3389\/fped.2019.00394","journal-title":"Front Pediatr"},{"key":"6227_CR108","doi-asserted-by":"publisher","first-page":"6429","DOI":"10.1007\/s12035-022-02984-3","volume":"59","author":"MET Oliveira","year":"2022","unstructured":"Oliveira MET, Paulino GV, dos Santos J\u00fanior ED, da Silva Oliveira FA, Melo VM, Ursulino JS, de Aquino TM, Shetty AK et al (2022) Multi-omic analysis of the gut microbiome in rats with lithium-pilocarpine-induced temporal lobe epilepsy. Mol Neurobiol 59:6429\u20136446. https:\/\/doi.org\/10.1007\/s12035-022-02984-3","journal-title":"Mol Neurobiol"},{"key":"6227_CR109","doi-asserted-by":"publisher","first-page":"106469","DOI":"10.1016\/j.nbd.2024.106469","volume":"194","author":"A Riva","year":"2024","unstructured":"Riva A, Sahin E, Volpedo G, Petretto A, Lavarello C, Di Sapia R, Barbarossa D, Zaniani NR et al (2024) Identification of an epilepsy-linked gut microbiota signature in a pediatric rat model of acquired epilepsy. Neurobiol Dis 194:106469. https:\/\/doi.org\/10.1016\/j.nbd.2024.106469","journal-title":"Neurobiol Dis"},{"key":"6227_CR110","doi-asserted-by":"publisher","DOI":"10.1016\/j.eplepsyres.2021.106601","volume":"172","author":"H Lee","year":"2021","unstructured":"Lee H, Lee S, Lee D-H, Kim DW (2021) A comparison of the gut microbiota among adult patients with drug-responsive and drug-resistant epilepsy: an exploratory study. Epilepsy Res 172:106601. https:\/\/doi.org\/10.1016\/j.eplepsyres.2021.106601","journal-title":"Epilepsy Res"},{"key":"6227_CR111","doi-asserted-by":"publisher","DOI":"10.1093\/ismeco\/ycae123","volume":"4","author":"C Dop","year":"2024","unstructured":"Dop C, Auvin S, Mondot S, Lepage P, Ilhan ZE (2024) Longitudinal exposure to antiseizure medications shape gut-derived microbiome, resistome, and metabolome landscape. ISME Commun 4:ycae123. https:\/\/doi.org\/10.1093\/ismeco\/ycae123","journal-title":"ISME Commun"},{"key":"6227_CR112","doi-asserted-by":"publisher","DOI":"10.20517\/mrr.2023.24","volume":"2","author":"M Mengoli","year":"2023","unstructured":"Mengoli M, Conti G, Fabbrini M, Candela M, Brigidi P, Turroni S, Barone M (2023) Microbiota-gut-brain axis and ketogenic diet: how close are we to tackling epilepsy? Microbiome Res Rep 2:32. https:\/\/doi.org\/10.20517\/mrr.2023.24","journal-title":"Microbiome Res Rep"},{"key":"6227_CR113","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1038\/s41586-020-2881-9","volume":"587","author":"I Vujkovic-Cvijin","year":"2020","unstructured":"Vujkovic-Cvijin I, Sklar J, Jiang L, Natarajan L, Knight R, Belkaid Y (2020) Host variables confound gut microbiota studies of human disease. Nature 587:448\u2013454. https:\/\/doi.org\/10.1038\/s41586-020-2881-9","journal-title":"Nature"},{"key":"6227_CR114","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1038\/s41467-019-14177-z","volume":"11","author":"A Vich Vila","year":"2020","unstructured":"Vich Vila A, Collij V, Sanna S, Sinha T, Imhann F, Bourgonje AR, Mujagic Z, Jonkers D et al (2020) Impact of commonly used drugs on the composition and metabolic function of the gut microbiota. Nat Commun 11:362. https:\/\/doi.org\/10.1038\/s41467-019-14177-z","journal-title":"Nat Commun"},{"key":"6227_CR115","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2022.994270","volume":"15","author":"Y Ouyang","year":"2022","unstructured":"Ouyang Y, Chen Y, Wang G, Song Y, Zhao H, Xiao B, Yang Z, Long L (2022) Genetically proxied gut microbiota, gut metabolites with risk of epilepsy and the subtypes: a bi-directional Mendelian randomization study. Front Mol Neurosci 15:994270. https:\/\/doi.org\/10.3389\/fnmol.2022.994270","journal-title":"Front Mol Neurosci"},{"key":"6227_CR116","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2023.1115014","volume":"14","author":"Y Zeng","year":"2023","unstructured":"Zeng Y, Cao S, Yang H (2023) Roles of gut microbiome in epilepsy risk: a Mendelian randomization study. Front Microbiol 14:1115014. https:\/\/doi.org\/10.3389\/fmicb.2023.1115014","journal-title":"Front Microbiol"},{"key":"6227_CR117","doi-asserted-by":"publisher","first-page":"105924","DOI":"10.1016\/j.neuint.2024.105924","volume":"183","author":"X Wang","year":"2024","unstructured":"Wang X, Duan H, Lu F, Yu X, Xie M, Chen P, Zou J, Gao L et al (2024) Anatomizing causal relationships between gut microbiota, plasma metabolites, and epilepsy: a Mendelian randomization study. Neurochem Int 183:105924. https:\/\/doi.org\/10.1016\/j.neuint.2024.105924","journal-title":"Neurochem Int"},{"key":"6227_CR118","doi-asserted-by":"publisher","DOI":"10.1002\/epi4.70325","author":"K Zammar","year":"2026","unstructured":"Zammar K, AbuAlrob MA, Ali M, Lattanzi S, Mesraoua B (2026) The gut microbiome and drug-resistant epilepsy: microbiome-antiseizure medication interactions and implications for pharmacoresistance. Epilepsia Open. https:\/\/doi.org\/10.1002\/epi4.70325","journal-title":"Epilepsia Open"},{"key":"6227_CR119","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2024.149385","volume":"1850","author":"N Khedpande","year":"2025","unstructured":"Khedpande N, Barve K (2025) Role of gut dysbiosis in drug-resistant epilepsy: pathogenesis and available therapeutic strategies. Brain Res 1850:149385. https:\/\/doi.org\/10.1016\/j.brainres.2024.149385","journal-title":"Brain Res"},{"key":"6227_CR120","doi-asserted-by":"publisher","first-page":"13983","DOI":"10.1038\/s41598-019-50542-0","volume":"9","author":"C De Caro","year":"2019","unstructured":"De Caro C, Leo A, Nesci V, Ghelardini C, di Cesare ML, Striano P, Avagliano C, Calignano A et al (2019) Intestinal inflammation increases convulsant activity and reduces antiepileptic drug efficacy in a mouse model of epilepsy. Sci Rep 9:13983. https:\/\/doi.org\/10.1038\/s41598-019-50542-0","journal-title":"Sci Rep"},{"key":"6227_CR121","doi-asserted-by":"publisher","first-page":"106588","DOI":"10.1016\/j.yebeh.2019.106588","volume":"101","author":"S H\u00f6hn","year":"2019","unstructured":"H\u00f6hn S, Dozi\u00e8res-Puyravel B, Auvin S (2019) History of dietary treatment from Wilder\u2019s hypothesis to the first open studies in the 1920s. Epilepsy Behav 101:106588. https:\/\/doi.org\/10.1016\/j.yebeh.2019.106588","journal-title":"Epilepsy Behav"},{"key":"6227_CR122","doi-asserted-by":"publisher","DOI":"10.1016\/j.eplepsyres.2020.106409","volume":"166","author":"QJ Pittman","year":"2020","unstructured":"Pittman QJ (2020) A gut feeling about the ketogenic diet in epilepsy. Epilepsy Res 166:106409. https:\/\/doi.org\/10.1016\/j.eplepsyres.2020.106409","journal-title":"Epilepsy Res"},{"key":"6227_CR123","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-021-00831-w","volume":"7","author":"H Zhu","year":"2022","unstructured":"Zhu H, Bi D, Zhang Y, Kong C, Du J, Wu X, Wei Q, Qin H (2022) Ketogenic diet for human diseases: the underlying mechanisms and potential for clinical implementations. Signal Transduct Target Ther 7:11. https:\/\/doi.org\/10.1038\/s41392-021-00831-w","journal-title":"Signal Transduct Target Ther"},{"key":"6227_CR124","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2020.109913","volume":"101","author":"AK Kraeuter","year":"2020","unstructured":"Kraeuter AK, Phillips R, Sarnyai Z (2020) Ketogenic therapy in neurodegenerative and psychiatric disorders: from mice to men. Prog Neuropsychopharmacol Biol Psychiatry 101:109913. https:\/\/doi.org\/10.1016\/j.pnpbp.2020.109913","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"6227_CR125","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.eplepsyres.2018.06.015","volume":"145","author":"Y Zhang","year":"2018","unstructured":"Zhang Y, Zhou S, Zhou Y, Yu L, Zhang L, Wang Y (2018) Altered gut microbiome composition in children with refractory epilepsy after ketogenic diet. Epilepsy Res 145:163\u2013168. https:\/\/doi.org\/10.1016\/j.eplepsyres.2018.06.015","journal-title":"Epilepsy Res"},{"key":"6227_CR126","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1038\/s41575-020-0344-2","volume":"17","author":"KS Swanson","year":"2020","unstructured":"Swanson KS, Gibson GR, Hutkins R, Reimer RA, Reid G, Verbeke K, Scott KP, Holscher HD et al (2020) The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of synbiotics. Nat Rev Gastroenterol Hepatol 17:687\u2013701. https:\/\/doi.org\/10.1038\/s41575-020-0344-2","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"6227_CR127","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.yebeh.2019.03.038","volume":"95","author":"S Bagheri","year":"2019","unstructured":"Bagheri S, Heydari A, Alinaghipour A, Salami M (2019) Effect of probiotic supplementation on seizure activity and cognitive performance in PTZ-induced chemical kindling. Epilepsy Behav 95:43\u201350. https:\/\/doi.org\/10.1016\/j.yebeh.2019.03.038","journal-title":"Epilepsy Behav"},{"key":"6227_CR128","doi-asserted-by":"publisher","first-page":"108830","DOI":"10.1016\/j.jnutbio.2021.108830","volume":"98","author":"E Kilinc","year":"2021","unstructured":"Kilinc E, Ankarali S, Ayhan D, Ankarali H, Torun IE, Cetinkaya A (2021) Protective effects of long-term probiotic mixture supplementation against pentylenetetrazole-induced seizures, inflammation and oxidative stress in rats. J Nutr Biochem 98:108830. https:\/\/doi.org\/10.1016\/j.jnutbio.2021.108830","journal-title":"J Nutr Biochem"},{"key":"6227_CR129","doi-asserted-by":"publisher","DOI":"10.1016\/j.eplepsyres.2023.107190","volume":"195","author":"AC Ciltas","year":"2023","unstructured":"Ciltas AC, Toy CE, G\u00fcne\u015f H, Yaprak M (2023) Effects of probiotics on GABA\/glutamate and oxidative stress in PTZ-induced acute seizure model in rats. Epilepsy Res 195:107190. https:\/\/doi.org\/10.1016\/j.eplepsyres.2023.107190","journal-title":"Epilepsy Res"},{"key":"6227_CR130","doi-asserted-by":"publisher","first-page":"8451","DOI":"10.3390\/ijms24098451","volume":"24","author":"OE Zubareva","year":"2023","unstructured":"Zubareva OE, Dyomina AV, Kovalenko AA, Roginskaya AI, Melik-Kasumov TB, Korneeva MA, Chuprina AV, Zhabinskaya AA et al (2023) Beneficial effects of probiotic Bifidobacterium longum in a Lithium\u2013pilocarpine model of temporal lobe epilepsy in rats. Int J Mol Sci 24:8451. https:\/\/doi.org\/10.3390\/ijms24098451","journal-title":"Int J Mol Sci"},{"key":"6227_CR131","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.yebeh.2015.11.013","volume":"54","author":"A Warburton","year":"2016","unstructured":"Warburton A, Miyajima F, Shazadi K, Crossley J, Johnson MR, Marson AG, Baker GA, Quinn JP et al (2016) NRSF and BDNF polymorphisms as biomarkers of cognitive dysfunction in adults with newly diagnosed epilepsy. Epilepsy Behav 54:117\u2013127. https:\/\/doi.org\/10.1016\/j.yebeh.2015.11.013","journal-title":"Epilepsy Behav"},{"key":"6227_CR132","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.neuroscience.2015.11.046","volume":"314","author":"G Mart\u00ednez-Levy","year":"2016","unstructured":"Mart\u00ednez-Levy G, Rocha L, Lubin FD, Alonso-Vanegas MA, Nani A, Buentello-Garc\u00eda RM, P\u00e9rez-Molina R, Briones-Velasco M et al (2016) Increased expression of BDNF transcript with exon VI in hippocampi of patients with pharmaco-resistant temporal lobe epilepsy. Neuroscience 314:12\u201321. https:\/\/doi.org\/10.1016\/j.neuroscience.2015.11.046","journal-title":"Neuroscience"},{"key":"6227_CR133","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.tips.2006.10.002","volume":"27","author":"M Simonato","year":"2006","unstructured":"Simonato M, Tongiorgi E, Kokaia M (2006) Angels and demons: neurotrophic factors and epilepsy. Trends Pharmacol Sci 27:631\u2013638. https:\/\/doi.org\/10.1016\/j.tips.2006.10.002","journal-title":"Trends Pharmacol Sci"},{"key":"6227_CR134","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2022.108588","volume":"128","author":"H Aygun","year":"2022","unstructured":"Aygun H, Akin AT, K\u0131z\u0131laslan N, Sumbul O, Karabulut D (2022) Probiotic supplementation alleviates absence seizures and anxiety-and depression-like behavior in WAG\/Rij rat by increasing neurotrophic factors and decreasing proinflammatory cytokines. Epilepsy Behav 128:108588. https:\/\/doi.org\/10.1016\/j.yebeh.2022.108588","journal-title":"Epilepsy Behav"},{"key":"6227_CR135","doi-asserted-by":"publisher","first-page":"111661","DOI":"10.1016\/j.biopha.2021.111661","volume":"139","author":"R Mirzaei","year":"2021","unstructured":"Mirzaei R, Bouzari B, Hosseini-Fard SR, Mazaheri M, Ahmadyousefi Y, Abdi M, Jalalifar S, Karimitabar Z et al (2021) Role of microbiota-derived short-chain fatty acids in nervous system disorders. Biomed Pharmacother 139:111661. https:\/\/doi.org\/10.1016\/j.biopha.2021.111661","journal-title":"Biomed Pharmacother"},{"key":"6227_CR136","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1001\/jama.2017.12865","volume":"320","author":"T Hampton","year":"2018","unstructured":"Hampton T (2018) Gut microbes may account for the anti-seizure effects of the ketogenic diet. JAMA 320:1307. https:\/\/doi.org\/10.1001\/jama.2017.12865","journal-title":"JAMA"},{"key":"6227_CR137","doi-asserted-by":"publisher","DOI":"10.1016\/j.fufo.2025.100680","volume":"12","author":"S Ali","year":"2025","unstructured":"Ali S, Hamayun M, Siraj M, Khan SA, Kim HY, Lee BJ (2025) Recent advances in prebiotics: classification, mechanisms, and health applications. Future Foods 12:100680. https:\/\/doi.org\/10.1016\/j.fufo.2025.100680","journal-title":"Future Foods"},{"key":"6227_CR138","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1038\/ajg.2013.4","volume":"108","author":"CM Surawicz","year":"2013","unstructured":"Surawicz CM, Brandt LJ, Binion DG, Ananthakrishnan AN, Curry SR, Gilligan PH, McFarland LV, Mellow M et al (2013) Guidelines for diagnosis, treatment, and prevention of Clostridium difficile infections. Am J Gastroenterol 108:478\u2013498. https:\/\/doi.org\/10.1038\/ajg.2013.4","journal-title":"Am J Gastroenterol"},{"key":"6227_CR139","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1159\/000449092","volume":"35","author":"W Reinisch","year":"2017","unstructured":"Reinisch W (2017) Fecal microbiota transplantation in inflammatory bowel disease. Dig Dis 35:123\u2013126. https:\/\/doi.org\/10.1159\/000449092","journal-title":"Dig Dis"},{"key":"6227_CR140","doi-asserted-by":"publisher","first-page":"98","DOI":"10.3389\/fcimb.2020.00098","volume":"10","author":"KEW Vendrik","year":"2020","unstructured":"Vendrik KEW, Ooijevaar RE, de Jong PRC, Laman JD, van Oosten BW, van Hilten JJ, Ducarmon QR, Keller JJ et al (2020) Fecal microbiota transplantation in neurological disorders. Front Cell Infect Microbiol 10:98. https:\/\/doi.org\/10.3389\/fcimb.2020.00098","journal-title":"Front Cell Infect Microbiol"},{"key":"6227_CR141","doi-asserted-by":"publisher","first-page":"3565","DOI":"10.3748\/wjg.v23.i19.3565","volume":"23","author":"Z He","year":"2017","unstructured":"He Z, Cui B-T, Zhang T, Li P, Long C-Y, Ji G-Z, Zhang F-M (2017) Fecal microbiota transplantation cured epilepsy in a case with Crohn\u2019s disease: the first report. World J Gastroenterol 23:3565. https:\/\/doi.org\/10.3748\/wjg.v23.i19.3565","journal-title":"World J Gastroenterol"},{"key":"6227_CR142","doi-asserted-by":"publisher","first-page":"1385469","DOI":"10.3389\/fvets.2024.1385469","volume":"11","author":"A Watanangura","year":"2024","unstructured":"Watanangura A, Meller S, Farhat N, Suchodolski JS, Pilla R, Khattab MR, Lopes BC, Bathen-N\u00f6then A et al (2024) Behavioral comorbidities treatment by fecal microbiota transplantation in canine epilepsy: a pilot study of a novel therapeutic approach. Front Vet Sci 11:1385469. https:\/\/doi.org\/10.3389\/fvets.2024.1385469","journal-title":"Front Vet Sci"},{"key":"6227_CR143","doi-asserted-by":"publisher","DOI":"10.1155\/2024\/9919868","author":"MA Madkour","year":"2024","unstructured":"Madkour MA, Altaf RA, Sayed ZS, Yasen NS, Elbary HA, Elsayed RA, Mohamed EN, Toema M et al (2024) The role of gut microbiota in modulating cancer therapy efficacy. Adv Gut Microbiome Res. https:\/\/doi.org\/10.1155\/2024\/9919868","journal-title":"Adv Gut Microbiome Res"},{"key":"6227_CR144","doi-asserted-by":"publisher","first-page":"3587","DOI":"10.1038\/s41380-026-03478-7","volume":"31","author":"AMC Ho","year":"2026","unstructured":"Ho AMC, Coombes BJ, Batzler A, Pazdernik VK, Pendegraft RS, Skime M, Bendjemaa N, Carpiniello B et al (2026) Pharmacogenomics of antiepileptic drug mood stabilizer treatment response in bipolar disorder: a MoStGen Consortium study. Mol Psychiatry 31:3587\u20133594. https:\/\/doi.org\/10.1038\/s41380-026-03478-7","journal-title":"Mol Psychiatry"},{"key":"6227_CR145","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1001\/jamaneurol.2019.2384","volume":"76","author":"H Kearney","year":"2019","unstructured":"Kearney H, Byrne S, Cavalleri GL, Delanty N (2019) Tackling epilepsy with high-definition precision medicine: a review. JAMA Neurol 76:1109\u20131116. https:\/\/doi.org\/10.1001\/jamaneurol.2019.2384","journal-title":"JAMA Neurol"},{"key":"6227_CR146","doi-asserted-by":"publisher","first-page":"e10296","DOI":"10.1002\/btm2.10296","volume":"7","author":"F Fusco","year":"2022","unstructured":"Fusco F, Perottoni S, Giordano C, Riva A, Iannone LF, De Caro C, Russo E, Albani D et al (2022) The microbiota-gut-brain axis and epilepsy from a multidisciplinary perspective: Clinical evidence and technological solutions for improvement of in vitro preclinical models. Bioeng Transl Med 7:e10296. https:\/\/doi.org\/10.1002\/btm2.10296","journal-title":"Bioeng Transl Med"},{"key":"6227_CR147","doi-asserted-by":"publisher","first-page":"813204","DOI":"10.3389\/fmed.2022.813204","volume":"9","author":"L Mitrea","year":"2022","unstructured":"Mitrea L, Neme\u015f S-A, Szabo K, Teleky B-E, Vodnar D-C (2022) Guts imbalance imbalances the brain: a review of gut microbiota association with neurological and psychiatric disorders. Front Med 9:813204. https:\/\/doi.org\/10.3389\/fmed.2022.813204","journal-title":"Front Med"},{"key":"6227_CR148","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1038\/s41579-020-00460-0","volume":"19","author":"LH Morais","year":"2021","unstructured":"Morais LH, Schreiber IVHL, Mazmanian SK (2021) The gut microbiota\u2013brain axis in behaviour and brain disorders. Nat Rev Microbiol 19:241\u2013255. https:\/\/doi.org\/10.1038\/s41579-020-00460-0","journal-title":"Nat Rev Microbiol"},{"key":"6227_CR149","doi-asserted-by":"publisher","first-page":"803","DOI":"10.3748\/wjg.v21.i3.803","volume":"21","author":"W-L Wang","year":"2015","unstructured":"Wang W-L, Xu S-Y, Ren Z-G, Tao L, Jiang J-W, Zheng S-S (2015) Application of metagenomics in the human gut microbiome. World J Gastroenterol 21:803. https:\/\/doi.org\/10.3748\/wjg.v21.i3.803","journal-title":"World J Gastroenterol"},{"key":"6227_CR150","doi-asserted-by":"publisher","DOI":"10.3390\/brainsci14111051","volume":"14","author":"N Belnap","year":"2024","unstructured":"Belnap N, Ramsey K, Carvalho ST, Nearman L, Haas H, Huentelman M, Lee K (2024) Exploring the frontier: the human microbiome\u2019s role in rare childhood neurological diseases and epilepsy. Brain Sci 14:1051. https:\/\/doi.org\/10.3390\/brainsci14111051","journal-title":"Brain Sci"},{"key":"6227_CR151","doi-asserted-by":"publisher","DOI":"10.1186\/s40035-024-00404-1","volume":"13","author":"Y-Y Ma","year":"2024","unstructured":"Ma Y-Y, Li X, Yu J-T, Wang Y-J (2024) Therapeutics for neurodegenerative diseases by targeting the gut microbiome: from bench to bedside. Transl Neurodegener 13:12. https:\/\/doi.org\/10.1186\/s40035-024-00404-1","journal-title":"Transl Neurodegener"},{"key":"6227_CR152","doi-asserted-by":"publisher","first-page":"3121","DOI":"10.3390\/ani11113121","volume":"11","author":"S Garc\u00eda-Belenguer","year":"2021","unstructured":"Garc\u00eda-Belenguer S, Grasa L, Valero O, Palacio J, Lu\u00f1o I, Rosado B (2021) Gut microbiota in canine idiopathic epilepsy: effects of disease and treatment. Anim: An Open Access J MDPI 11:3121. https:\/\/doi.org\/10.3390\/ani11113121","journal-title":"Anim: An Open Access J MDPI"},{"key":"6227_CR153","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1080\/17512433.2020.1759414","volume":"13","author":"LF Iannone","year":"2020","unstructured":"Iannone LF, G\u00f3mez-Egu\u00edlaz M, Citaro R, Russo E (2020) The potential role of interventions impacting on gut-microbiota in epilepsy. Expert Rev Clin Pharmacol 13:423\u2013435. https:\/\/doi.org\/10.1080\/17512433.2020.1759414","journal-title":"Expert Rev Clin Pharmacol"},{"key":"6227_CR154","doi-asserted-by":"publisher","unstructured":"Ceccarani C (2021) Epilepsy and microbiota: time- and drug-related shifts in the bacterial community. Dissertation, University of Milan. https:\/\/doi.org\/10.13130\/ceccarani-camilla_phd2021-01-21","DOI":"10.13130\/ceccarani-camilla_phd2021-01-21"},{"key":"6227_CR155","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1007\/s00018-021-04060-w","volume":"79","author":"A Chakrabarti","year":"2022","unstructured":"Chakrabarti A, Geurts L, Hoyles L, Iozzo P, Kraneveld AD, La Fata G, Miani M, Patterson E, et al. (2022) The microbiota\u2013gut\u2013brain axis: pathways to better brain health. Perspectives on what we know, what we need to investigate and how to put knowledge into practice. Cell Mol Life Sci 79:80. https:\/\/doi.org\/10.1007\/s00018-021-04060-w","journal-title":"Cell Mol Life Sci"},{"key":"6227_CR156","doi-asserted-by":"publisher","first-page":"559","DOI":"10.2174\/1570159X15666170915141036","volume":"16","author":"Y-K Kim","year":"2018","unstructured":"Kim Y-K, Shin C (2018) The microbiota-gut-brain axis in neuropsychiatric disorders: pathophysiological mechanisms and novel treatments. Curr Neuropharmacol 16:559\u2013573. https:\/\/doi.org\/10.2174\/1570159X15666170915141036","journal-title":"Curr Neuropharmacol"},{"key":"6227_CR157","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/bs.pmbts.2020.08.011","volume":"176","author":"LM Hopson","year":"2020","unstructured":"Hopson LM, Singleton SS, David JA, Basuchoudhary A, Prast-Nielsen S, Klein P, Sen S, Mazumder R (2020) Bioinformatics and machine learning in gastrointestinal microbiome research and clinical application. Prog Mol Biol Transl Sci 176:141\u2013178. https:\/\/doi.org\/10.1016\/bs.pmbts.2020.08.011","journal-title":"Prog Mol Biol Transl Sci"},{"key":"6227_CR158","unstructured":"Lum GRT (2023) Effects of clinical ketogenic diet therapy for pediatric epilepsy on the gut microbiota and seizure resistance.\u00a0Doctoral dissertation, University of California, Los Angeles, USA. https:\/\/escholarship.org\/uc\/item\/8s773849"},{"key":"6227_CR159","doi-asserted-by":"publisher","first-page":"1742","DOI":"10.3390\/diagnostics12071742","volume":"12","author":"R Hajjo","year":"2022","unstructured":"Hajjo R, Sabbah DA, Al Bawab AQ (2022) Unlocking the potential of the human microbiome for identifying disease diagnostic biomarkers. Diagnostics 12:1742. https:\/\/doi.org\/10.3390\/diagnostics12071742","journal-title":"Diagnostics"},{"key":"6227_CR160","first-page":"302","volume":"9","author":"AS Kumar","year":"2017","unstructured":"Kumar AS, Kuruvila T, Kavya S, Radhakrishnan R, Nair AJ, Kamalasanan K (2017) Early detection of seizures in epilepsy using point of care (POC) systems. J Pharm Sci Res 9:302","journal-title":"J Pharm Sci Res"},{"key":"6227_CR161","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1038\/s41579-021-00667-9","volume":"20","author":"MT Sorbara","year":"2022","unstructured":"Sorbara MT, Pamer EG (2022) Microbiome-based therapeutics. Nat Rev Microbiol 20:365\u2013380. https:\/\/doi.org\/10.1038\/s41579-021-00667-9","journal-title":"Nat Rev Microbiol"},{"key":"6227_CR162","doi-asserted-by":"publisher","first-page":"1855","DOI":"10.1016\/j.mayocp.2017.10.004","volume":"92","author":"PC Kashyap","year":"2017","unstructured":"Kashyap PC, Chia N, Nelson H, Segal E, Elinav E (2017) Microbiome at the frontier of personalized medicine. Mayo Clin Proc 92:1855\u20131864. https:\/\/doi.org\/10.1016\/j.mayocp.2017.10.004","journal-title":"Mayo Clin Proc"},{"key":"6227_CR163","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.seizure.2020.04.011","volume":"80","author":"A McKinlay","year":"2020","unstructured":"McKinlay A, Morgan M, Noble A, Ridsdale L (2020) Patient views on use of emergency and alternative care services for adult epilepsy: a qualitative study. Seizure 80:56\u201362. https:\/\/doi.org\/10.1016\/j.seizure.2020.04.011","journal-title":"Seizure"},{"key":"6227_CR164","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1007\/s00125-017-4278-3","volume":"60","author":"L Brunkwall","year":"2017","unstructured":"Brunkwall L, Orho-Melander M (2017) The gut microbiome as a target for prevention and treatment of hyperglycaemia in type 2 diabetes: from current human evidence to future possibilities. Diabetologia 60:943\u2013951. https:\/\/doi.org\/10.1007\/s00125-017-4278-3","journal-title":"Diabetologia"},{"key":"6227_CR165","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1016\/j.neubiorev.2019.10.002","volume":"107","author":"C De Caro","year":"2019","unstructured":"De Caro C, Iannone LF, Citraro R, Striano P, De Sarro G, Constanti A, Cryan JF, Russo E (2019) Can we \u2018seize\u2019 the gut microbiota to treat epilepsy? Neurosci Biobehav Rev 107:750\u2013764. https:\/\/doi.org\/10.1016\/j.neubiorev.2019.10.002","journal-title":"Neurosci Biobehav Rev"},{"key":"6227_CR166","doi-asserted-by":"publisher","DOI":"10.1186\/s12887-024-05134-x","volume":"24","author":"F Shariatmadari","year":"2024","unstructured":"Shariatmadari F, Motaghi A, Arjmand Shabestari A, Hashemi SM, Almasi-Hashiani A (2024) The effect of synbiotics in the treatment of drug-resistant epilepsy and the parental burden of caregivers: a single-arm pretest-posttest trial. BMC Pediatr 24:666. https:\/\/doi.org\/10.1186\/s12887-024-05134-x","journal-title":"BMC Pediatr"},{"key":"6227_CR167","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.brainresbull.2020.12.009","volume":"168","author":"D Li","year":"2021","unstructured":"Li D, Bai X, Jiang Y, Cheng Y (2021) Butyrate alleviates PTZ-induced mitochondrial dysfunction, oxidative stress and neuron apoptosis in mice via Keap1\/Nrf2\/HO-1 pathway. Brain Res Bull 168:25\u201335. https:\/\/doi.org\/10.1016\/j.brainresbull.2020.12.009","journal-title":"Brain Res Bull"},{"key":"6227_CR168","doi-asserted-by":"publisher","DOI":"10.1016\/j.eplepsyres.2021.106668","volume":"174","author":"JY Eor","year":"2021","unstructured":"Eor JY, Son YJ, Kim J-Y, Kang H-C, Youn SE, Kim JH, Kim SH (2021) Neuroprotective effect of both synbiotics and ketogenic diet in a pentylenetetrazol-induced acute seizure murine model. Epilepsy Res 174:106668. https:\/\/doi.org\/10.1016\/j.eplepsyres.2021.106668","journal-title":"Epilepsy Res"},{"key":"6227_CR169","doi-asserted-by":"publisher","DOI":"10.3390\/cells12131720","volume":"12","author":"A J\u0119drusiak","year":"2023","unstructured":"J\u0119drusiak A, Fortuna W, Majewska J, G\u00f3rski A, Jo\u0144czyk-Matysiak E (2023) Phage interactions with the nervous system in health and disease. Cells 12:1720. https:\/\/doi.org\/10.3390\/cells12131720","journal-title":"Cells"},{"key":"6227_CR170","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26136183","volume":"26","author":"V Salari","year":"2025","unstructured":"Salari V, Parrella E, Mengoni F, Cintra L, Bertini G, Fabene PF (2025) Phage-microbiota crosstalk: implications for central nervous system disorders. Int J Mol Sci 26:6183. https:\/\/doi.org\/10.3390\/ijms26136183","journal-title":"Int J Mol Sci"},{"key":"6227_CR171","first-page":"187","volume-title":"IAN Reviews in Neurology 2022: Epilepsy\u2014Innovations and Advances","author":"S Agrawal","year":"2022","unstructured":"Agrawal S, Sankaraneni R, Singh SP (2022) Future of epilepsy management. In: Sylaja PN (ed) IAN Reviews in Neurology 2022: Epilepsy\u2014Innovations and Advances. Jaypee Brothers Medical Publishers, New Delhi, p 187"},{"key":"6227_CR172","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1080\/02648725.2023.2196476","volume":"40","author":"J Mukherjee","year":"2023","unstructured":"Mukherjee J, Sharma R, Dutta P, Bhunia B (2023) Artificial intelligence in healthcare: a mastery. Biotechnol Genet Eng Rev 40:1659\u20131708. https:\/\/doi.org\/10.1080\/02648725.2023.2196476","journal-title":"Biotechnol Genet Eng Rev"},{"key":"6227_CR173","doi-asserted-by":"publisher","DOI":"10.1093\/database\/baaa010","author":"Z Ahmed","year":"2020","unstructured":"Ahmed Z, Mohamed K, Zeeshan S, Dong X (2020) Artificial intelligence with multi-functional machine learning platform development for better healthcare and precision medicine. Database. https:\/\/doi.org\/10.1093\/database\/baaa010","journal-title":"Database"},{"key":"6227_CR174","unstructured":"Baldassano SN (2017) Translational machine learning for epilepsy therapy.\u00a0Doctoral Dissertation, University of Pennsylvania,\u00a0Philadelphia, USA"},{"key":"6227_CR175","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.3390\/jpm13111590","volume":"13","author":"A Fawaz","year":"2023","unstructured":"Fawaz A, Ferraresi A, Isidoro C (2023) Systems biology in cancer diagnosis integrating omics technologies and artificial intelligence to support physician decision making. J Pers Med 13:1590. https:\/\/doi.org\/10.3390\/jpm13111590","journal-title":"J Pers Med"},{"key":"6227_CR176","doi-asserted-by":"publisher","first-page":"5883","DOI":"10.1007\/s40747-024-01346-x","volume":"10","author":"MBB Heyat","year":"2024","unstructured":"Heyat MBB, Akhtar F, Munir F, Sultana A, Muaad AY, Gul I, Sawan M, Asghar W, et al. (2024) Unravelling the complexities of depression with medical intelligence: exploring the interplay of genetics, hormones, and brain function. Complex Intell Syst 10:5883\u20135915. https:\/\/doi.org\/10.1007\/s40747-024-01346-x","journal-title":"Complex Intell Syst"},{"key":"6227_CR177","doi-asserted-by":"publisher","DOI":"10.5772\/intechopen.104048","volume-title":"Digital twin technology\u2014fundamentals and applications","year":"2023","unstructured":"M\u00e1rquez FPG, Korhan O (eds) (2023) Digital twin technology\u2014fundamentals and applications. IntechOpen. https:\/\/doi.org\/10.5772\/intechopen.104048"},{"key":"6227_CR178","doi-asserted-by":"publisher","DOI":"10.1016\/C2020-0-03088-4","volume-title":"Translational bioinformatics in healthcare and medicine","author":"K Raza","year":"2021","unstructured":"Raza K, Dey N (2021) Translational bioinformatics in healthcare and medicine. Acad Press. https:\/\/doi.org\/10.1016\/C2020-0-03088-4"},{"key":"6227_CR179","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1007\/s11019-014-9552-2","volume":"17","author":"V Baty","year":"2014","unstructured":"Baty V, Mougin B, Dekeuwer C, Carret G (2014) Gut health in the era of the human gut microbiota: from metaphor to biovalue. Med Health Care Philos 17:579\u2013597. https:\/\/doi.org\/10.1007\/s11019-014-9552-2","journal-title":"Med Health Care Philos"},{"key":"6227_CR180","unstructured":"Poolay Mootien C (2024) Knowledge, understanding, and attitudes towards antibiotic use, prescription advice and antibiotic resistance among parents in Greater Manchester.\u00a0Thesis, University of Salford, UK.\u00a0https:\/\/salford-repository.worktribe.com\/output\/2858631"},{"key":"6227_CR181","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1038\/s41368-022-00183-3","volume":"14","author":"J Bao","year":"2022","unstructured":"Bao J, Li L, Zhang Y, Wang M, Chen F, Ge S, Chen B, Yan F (2022) Periodontitis may induce gut microbiota dysbiosis via salivary microbiota. Int J Oral Sci 14:32. https:\/\/doi.org\/10.1038\/s41368-022-00183-3","journal-title":"Int J Oral Sci"},{"key":"6227_CR182","doi-asserted-by":"publisher","first-page":"2126272","DOI":"10.1080\/19490976.2022.2126272","volume":"14","author":"J Lu","year":"2022","unstructured":"Lu J, Zhang S, Huang Y, Qian J, Tan B, Qian X, Zhuang J, Zou X, et al. (2022) Periodontitis-related salivary microbiota aggravates Alzheimer\u2019s disease via gut-brain axis crosstalk. Gut Microbes 14:2126272. https:\/\/doi.org\/10.1080\/19490976.2022.2126272","journal-title":"Gut Microbes"},{"key":"6227_CR183","doi-asserted-by":"publisher","first-page":"2419","DOI":"10.1002\/epi4.13074","volume":"9","author":"C Zhao","year":"2024","unstructured":"Zhao C, Chen F, Li Q, Zhang W, Peng L, Yue C (2024) Causal relationship between oral microbiota and epilepsy risk: evidence from Mendelian randomization analysis in East Asians. Epilepsia Open 9:2419\u20132428. https:\/\/doi.org\/10.1002\/epi4.13074","journal-title":"Epilepsia Open"},{"key":"6227_CR184","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/nrmicro2973","volume":"11","author":"M Blaser","year":"2013","unstructured":"Blaser M, Bork P, Fraser C, Knight R, Wang J (2013) The microbiome explored: recent insights and future challenges. Nat Rev Microbiol 11:213\u2013217. https:\/\/doi.org\/10.1038\/nrmicro2973","journal-title":"Nat Rev Microbiol"},{"key":"6227_CR185","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.pediatrneurol.2023.04.006","volume":"145","author":"S T\u00fcray","year":"2023","unstructured":"T\u00fcray S, Cang\u00fcr \u015e, Kahraman G, Kayaba\u015f\u0131 E, \u00c7etiner \u00d6F, Ayd\u0131n B, \u00d6zt\u00fcrk CE (2023) Can the gut microbiota serve as a guide to the diagnosis and treatment of childhood epilepsy? Pediatr Neurol 145:11\u201321. https:\/\/doi.org\/10.1016\/j.pediatrneurol.2023.04.006","journal-title":"Pediatr Neurol"},{"key":"6227_CR186","doi-asserted-by":"publisher","first-page":"585973","DOI":"10.3389\/fcimb.2020.585973","volume":"10","author":"T Kishikawa","year":"2020","unstructured":"Kishikawa T, Ogawa K, Motooka D, Hosokawa A, Kinoshita M, Suzuki K, Yamamoto K, Masuda T et al (2020) A metagenome-wide association study of gut microbiome in patients with multiple sclerosis revealed novel disease pathology. Front Cell Infect Microbiol 10:585973. https:\/\/doi.org\/10.3389\/fcimb.2020.585973","journal-title":"Front Cell Infect Microbiol"},{"key":"6227_CR187","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1016\/j.bbrc.2015.12.083","volume":"469","author":"R Ranjan","year":"2016","unstructured":"Ranjan R, Rani A, Metwally A, McGee HS, Perkins DL (2016) Analysis of the microbiome: advantages of whole genome shotgun versus 16S amplicon sequencing. Biochem Biophys Res Commun 469:967\u2013977. https:\/\/doi.org\/10.1016\/j.bbrc.2015.12.083","journal-title":"Biochem Biophys Res Commun"},{"key":"6227_CR188","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2021.670336","volume":"12","author":"D Peterson","year":"2021","unstructured":"Peterson D, Bonham KS, Rowland S, Pattanayak CW, Consortium R, Klepac-Ceraj V (2021) Comparative analysis of 16S rRNA gene and metagenome sequencing in pediatric gut microbiomes. Front Microbiol 12:670336. https:\/\/doi.org\/10.3389\/fmicb.2021.670336","journal-title":"Front Microbiol"},{"key":"6227_CR189","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1186\/s12866-020-01801-y","volume":"20","author":"E Caselli","year":"2020","unstructured":"Caselli E, Fabbri C, D\u2019Accolti M, Soffritti I, Bassi C, Mazzacane S, Franchi M (2020) Defining the oral microbiome by whole-genome sequencing and resistome analysis: the complexity of the healthy picture. BMC Microbiol 20:120. https:\/\/doi.org\/10.1186\/s12866-020-01801-y","journal-title":"BMC Microbiol"},{"key":"6227_CR190","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.00525-18","volume":"9","author":"PD Schloss","year":"2018","unstructured":"Schloss PD (2018) Identifying and overcoming threats to reproducibility, replicability, robustness, and generalizability in microbiome research. MBio 9:e00525-18. https:\/\/doi.org\/10.1128\/mBio.00525-18","journal-title":"MBio"},{"key":"6227_CR191","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1038\/nrg.2017.63","volume":"18","author":"AB Hall","year":"2017","unstructured":"Hall AB, Tolonen AC, Xavier RJ (2017) Human genetic variation and the gut microbiome in disease. Nat Rev Genet 18:690\u2013699. https:\/\/doi.org\/10.1038\/nrg.2017.63","journal-title":"Nat Rev Genet"},{"key":"6227_CR192","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1053\/j.gastro.2020.09.057","volume":"160","author":"F Shanahan","year":"2021","unstructured":"Shanahan F, Ghosh TS, O\u2019Toole PW (2021) The healthy microbiome\u2014what is the definition of a healthy gut microbiome? Gastroenterology 160:483\u2013494. https:\/\/doi.org\/10.1053\/j.gastro.2020.09.057","journal-title":"Gastroenterology"},{"key":"6227_CR193","doi-asserted-by":"publisher","first-page":"28926","DOI":"10.1007\/s11356-021-13862-1","volume":"28","author":"A El-Sayed","year":"2021","unstructured":"El-Sayed A, Aleya L, Kamel M (2021) The link among microbiota, epigenetics, and disease development. Environ Sci Pollut Res 28:28926\u201328964. https:\/\/doi.org\/10.1007\/s11356-021-13862-1","journal-title":"Environ Sci Pollut Res"},{"key":"6227_CR194","doi-asserted-by":"publisher","first-page":"607","DOI":"10.3389\/fimmu.2019.00607","volume":"10","author":"H-Y Cheng","year":"2019","unstructured":"Cheng H-Y, Ning M-X, Chen D-K, Ma W-T (2019) Interactions between the gut microbiota and the host innate immune response against pathogens. Front Immunol 10:607. https:\/\/doi.org\/10.3389\/fimmu.2019.00607","journal-title":"Front Immunol"},{"key":"6227_CR195","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1111\/imr.12567","volume":"279","author":"JM Pickard","year":"2017","unstructured":"Pickard JM, Zeng MY, Caruso R, N\u00fa\u00f1ez G (2017) Gut microbiota: role in pathogen colonization, immune responses, and inflammatory disease. Immunol Rev 279:70\u201389. https:\/\/doi.org\/10.1111\/imr.12567","journal-title":"Immunol Rev"},{"key":"6227_CR196","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.3390\/microorganisms10071368","volume":"10","author":"E Nova","year":"2022","unstructured":"Nova E, G\u00f3mez-Martinez S, Gonz\u00e1lez-Soltero R (2022) The influence of dietary factors on the gut microbiota. Microorganisms 10:1368. https:\/\/doi.org\/10.3390\/microorganisms10071368","journal-title":"Microorganisms"},{"key":"6227_CR197","doi-asserted-by":"publisher","DOI":"10.3390\/nu12061776","volume":"12","author":"N Redondo-Useros","year":"2020","unstructured":"Redondo-Useros N, Nova E, Gonz\u00e1lez-Zancada N, D\u00edaz LE, G\u00f3mez-Mart\u00ednez S, Marcos A (2020) Microbiota and lifestyle: a special focus on diet. Nutrients 12:1776. https:\/\/doi.org\/10.3390\/nu12061776","journal-title":"Nutrients"},{"key":"6227_CR198","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.arcmed.2019.09.004","volume":"50","author":"M S\u00e1nchez-Tapia","year":"2019","unstructured":"S\u00e1nchez-Tapia M, Tovar AR, Torres N (2019) Diet as regulator of gut microbiota and its role in health and disease. Arch Med Res 50:259\u2013268. https:\/\/doi.org\/10.1016\/j.arcmed.2019.09.004","journal-title":"Arch Med Res"},{"key":"6227_CR199","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1016\/j.scitotenv.2018.01.288","volume":"627","author":"L Flandroy","year":"2018","unstructured":"Flandroy L, Poutahidis T, Berg G, Clarke G, Dao M-C, Decaestecker E, Furman E, Haahtela T et al (2018) The impact of human activities and lifestyles on the interlinked microbiota and health of humans and of ecosystems. Sci Total Environ 627:1018\u20131038. https:\/\/doi.org\/10.1016\/j.scitotenv.2018.01.288","journal-title":"Sci Total Environ"},{"key":"6227_CR200","doi-asserted-by":"publisher","unstructured":"Appanna VD, Appanna VD (2018) Dysbiosis, probiotics, and prebiotics: in diseases and health. Human microbes\u2014the power within: health, healing and beyond. Springer Nature Singapore, Singapore, p pp 81-122. https:\/\/doi.org\/10.1007\/978-981-10-7684-8_3","DOI":"10.1007\/978-981-10-7684-8_3"},{"key":"6227_CR201","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.bcp.2016.09.007","volume":"134","author":"M Ferrer","year":"2017","unstructured":"Ferrer M, M\u00e9ndez-Garc\u00eda C, Rojo D, Barbas C, Moya A (2017) Antibiotic use and microbiome function. Biochem Pharmacol 134:114\u2013126. https:\/\/doi.org\/10.1016\/j.bcp.2016.09.007","journal-title":"Biochem Pharmacol"},{"key":"6227_CR202","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1002\/ame2.12022","volume":"1","author":"PV Turner","year":"2018","unstructured":"Turner PV (2018) The role of the gut microbiota on animal model reproducibility. Anim Models Exp Med 1:109\u2013115. https:\/\/doi.org\/10.1002\/ame2.12022","journal-title":"Anim Models Exp Med"},{"key":"6227_CR203","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1093\/ilar\/ilv021","volume":"56","author":"AC Ericsson","year":"2015","unstructured":"Ericsson AC, Franklin CL (2015) Manipulating the gut microbiota: methods and challenges. ILAR J 56:205\u2013217. https:\/\/doi.org\/10.1093\/ilar\/ilv021","journal-title":"ILAR J"},{"key":"6227_CR204","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1016\/j.ebiom.2019.05.024","volume":"44","author":"M Dahlin","year":"2019","unstructured":"Dahlin M, Prast-Nielsen S (2019) The gut microbiome and epilepsy. EBioMedicine 44:741\u2013746. https:\/\/doi.org\/10.1016\/j.ebiom.2019.05.024","journal-title":"EBioMedicine"},{"key":"6227_CR205","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2019.104576","volume":"135","author":"GR Lum","year":"2020","unstructured":"Lum GR, Olson CA, Hsiao EY (2020) Emerging roles for the intestinal microbiome in epilepsy. Neurobiol Dis 135:104576. https:\/\/doi.org\/10.1016\/j.nbd.2019.104576","journal-title":"Neurobiol Dis"},{"key":"6227_CR206","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2023.1165787","volume":"14","author":"S Wei","year":"2023","unstructured":"Wei S, Mai Y, Hu L, Zheng R, Zheng D, Chen W, Cai Y, Wang J (2023) Altered gut microbiota in temporal lobe epilepsy with anxiety disorders. Front Microbiol 14:1165787. https:\/\/doi.org\/10.3389\/fmicb.2023.1165787","journal-title":"Front Microbiol"},{"key":"6227_CR207","doi-asserted-by":"publisher","unstructured":"Waheed R, Farooq AZ, Asma L (2024) Regulatory considerations for microbiome-based therapeutics. In: Khurshid M, Akash MSH (eds) Human microbiome: techniques, strategies, and therapeutic potential. Springer Singapore, Singapore, pp 657\u2013689. https:\/\/doi.org\/10.1007\/978-981-97-3790-1_21","DOI":"10.1007\/978-981-97-3790-1_21"},{"key":"6227_CR208","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/bs.pmbts.2022.03.002","volume":"190","author":"M Sahu","year":"2022","unstructured":"Sahu M, Gupta R, Ambasta RK, Kumar P (2022) Artificial intelligence and machine learning in precision medicine: a paradigm shift in big data analysis. Prog Mol Biol Transl Sci 190:57\u2013100. https:\/\/doi.org\/10.1016\/bs.pmbts.2022.03.002","journal-title":"Prog Mol Biol Transl Sci"},{"key":"6227_CR209","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4167\/jbv.2025.55.1.001","volume":"55","author":"A Khan","year":"2025","unstructured":"Khan A, Kim S, Hong ST (2025) Gut microbes libraries: a key resource for current gut microbiome research. J Bacteriol Virol 55:1\u20139. https:\/\/doi.org\/10.4167\/jbv.2025.55.1.001","journal-title":"J Bacteriol Virol"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-026-06227-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-026-06227-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-026-06227-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T23:05:17Z","timestamp":1791673517000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-026-06227-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":209,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["6227"],"URL":"https:\/\/doi.org\/10.1007\/s12035-026-06227-7","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"24 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics Approval and Consent to Participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for Publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"959"}}